|Articles|October 16, 2020
Fast and High-Resolution Reversed-Phase Separation of Synthetic Oligonucleotides
Author(s)Agilent
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
GSK’s Arexvy Gains EU Approval for Adults Aged 18 Years and Older
2
HanchorBio–WuXi Biologics Partnership Targets Fusion Protein Development Challenges
3
Optimizing Kinetics Assays to Avoid Avidity Effects
4
Green Chemistry’s Role in Advancing US Chemical Innovation
5